These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19925394)

  • 1. Targeting prostate cancer stem cells.
    Crea F; Mathews LA; Farrar WL; Hurt EM
    Anticancer Agents Med Chem; 2009 Dec; 9(10):1105-13. PubMed ID: 19925394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy.
    Leão R; Domingos C; Figueiredo A; Hamilton R; Tabori U; Castelo-Branco P
    Urol Int; 2017; 99(2):125-136. PubMed ID: 28142149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cell: target for anti-cancer therapy.
    Tang C; Ang BT; Pervaiz S
    FASEB J; 2007 Dec; 21(14):3777-85. PubMed ID: 17625071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells.
    Xie J; Mølck C; Paquet-Fifield S; Butler L; ; Sloan E; Ventura S; Hollande F
    Oncotarget; 2016 Jul; 7(28):44492-44504. PubMed ID: 27283984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of cancer stem cells in cancer drug development and drug delivery.
    Chow EK
    J Lab Autom; 2013 Feb; 18(1):6-11. PubMed ID: 22893634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma.
    Dubrovska A; Elliott J; Salamone RJ; Kim S; Aimone LJ; Walker JR; Watson J; Sauveur-Michel M; Garcia-Echeverria C; Cho CY; Reddy VA; Schultz PG
    Clin Cancer Res; 2010 Dec; 16(23):5692-702. PubMed ID: 21138868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver cancer stem cells as an important target in liver cancer therapies.
    Zou GM
    Anticancer Agents Med Chem; 2010 Feb; 10(2):172-5. PubMed ID: 20298161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective targeting of cancer stem cells: a new concept in cancer therapeutics.
    Korkaya H; Wicha MS
    BioDrugs; 2007; 21(5):299-310. PubMed ID: 17896836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agents targeting prostate cancer bone metastasis.
    Mohammad KS; Fournier PG; Guise TA; Chirgwin JM
    Anticancer Agents Med Chem; 2009 Dec; 9(10):1079-88. PubMed ID: 19719455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer stem cells: a new target for therapy.
    Maitland NJ; Collins AT
    J Clin Oncol; 2008 Jun; 26(17):2862-70. PubMed ID: 18539965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Apoptotic Activity Against Prostate Cancer Stem Cells.
    Jaworska D; Szliszka E
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.
    Bansal N; Bartucci M; Yusuff S; Davis S; Flaherty K; Huselid E; Patrizii M; Jones D; Cao L; Sydorenko N; Moon YC; Zhong H; Medina DJ; Kerrigan J; Stein MN; Kim IY; Davis TW; DiPaola RS; Bertino JR; Sabaawy HE
    Clin Cancer Res; 2016 Dec; 22(24):6176-6191. PubMed ID: 27307599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efflux Transporter ABCG2 Maintains Prostate Stem Cells.
    Sabnis NG; Miller A; Titus MA; Huss WJ
    Mol Cancer Res; 2017 Feb; 15(2):128-140. PubMed ID: 27856956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarriers targeting cancer stem cells: how to help drugs to find their way home.
    Visani G; Loscocco F; Isidori A
    Nanomedicine (Lond); 2015; 10(7):1043-6. PubMed ID: 25929562
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting the acute myeloid leukemia stem cells.
    Krause A; Luciana M; Krause F; Rego EM
    Anticancer Agents Med Chem; 2010 Feb; 10(2):104-10. PubMed ID: 20184541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials.
    Pollyea DA; Gutman JA; Gore L; Smith CA; Jordan CT
    Haematologica; 2014 Aug; 99(8):1277-84. PubMed ID: 25082785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
    Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
    Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in the study of targeted drug delivery systems for cancer stem cells].
    Qiao MX; Zhang XJ; Shuang BA; Hu HY; Zhao XL; Chen DW
    Yao Xue Xue Bao; 2013 Apr; 48(4):477-83. PubMed ID: 23833932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells as a target population for drug discovery.
    Bouvard C; Barefield C; Zhu S
    Future Med Chem; 2014 Sep; 6(14):1567-85. PubMed ID: 25367391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.
    El-Merahbi R; Liu YN; Eid A; Daoud G; Hosry L; Monzer A; Mouhieddine TH; Hamade A; Najjar F; Abou-Kheir W
    PLoS One; 2014; 9(11):e112453. PubMed ID: 25380390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.